Abacus Life (NASDAQ:ABL - Get Free Report) is anticipated to post its quarterly earnings results after the market closes on Thursday, March 27th. Analysts expect Abacus Life to post earnings of $0.14 per share and revenue of $28.76 million for the quarter. Individual interested in registering for the company's earnings conference call can do so using this link.
Abacus Life Trading Up 3.0 %
Abacus Life stock traded up $0.22 during trading on Friday, hitting $7.64. The company had a trading volume of 1,156,261 shares, compared to its average volume of 136,964. Abacus Life has a 1-year low of $6.75 and a 1-year high of $12.50. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.65. The company's 50 day simple moving average is $7.62 and its 200-day simple moving average is $8.38. The stock has a market cap of $738.37 million, a price-to-earnings ratio of -42.44 and a beta of 0.14.
Analyst Upgrades and Downgrades
Separately, B. Riley dropped their price target on shares of Abacus Life from $17.00 to $15.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Abacus Life currently has a consensus rating of "Buy" and an average target price of $14.30.
Check Out Our Latest Stock Report on ABL
About Abacus Life
(
Get Free Report)
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
See Also
Before you consider Abacus Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abacus Life wasn't on the list.
While Abacus Life currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
